Elranatamab
Definition: Elranatamab, sold under the brand name Elrexfio, is a medication used for the treatment of multiple myeloma. Elranatamab is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager. Elranatamab is given by subcutaneous injection. source: Wikipedia
- ID
- 2054141000122109
- ID date
- 25 Apr 2025
- Previous ID
- 42566111000001103
- Name
- Elranatamab